October 20, 2011
Otsuka Pharmaceutical Factory (OPF) announced on October 19 that the company entered into a joint venture agreement on October 18 with Living Cell Technologies (LCT) based in Auckland, New Zealand, to develop and commercialize pancreatic islet cells, (brand name: Diabecell),...read more